Showing results (251-260 of 356) with videos related to
Sort By:
Pageof 36
Neuro-Oncology Advances|March 24, 2020
Primary CNS lymphoma commonly expresses immune response biomarkersAlexander Ou, Ashley Sumrall, Surasak Phuphanich, et al.BMC Neurology|June 24, 2021
Gliosarcoma vs. glioblastoma: a retrospective case series using molecular profilingChristopher Dardis, David Donner, Nader Sanai, et al.Oncotarget|September 1, 2016
GBM-associated mutations and altered protein expression are more common in young patientsSherise D Ferguson, Joanne Xiu, Shiao-Pei Weathers, et al.European Journal of Cancer (Oxford, England : 1990)|February 17, 2010
Treating triple-negative breast cancer by a combination of rapamycin and cyclophosphamide: an in vivo bioluminescence imaging studyQing Zeng, Zhong Yang, Yong-Jing Gao, et al.Journal of Translational Medicine|March 11, 2018
Clinical feasibility of umbilical cord tissue-derived mesenchymal stem cells in the treatment of multiple sclerosisNeil H Riordan, Isabela Morales, Giselle Fernández, et al.Neuro-Oncology Advances|April 29, 2024
A phase I dose-escalation study of pulsatile afatinib in patients with recurrent or progressive brain cancerTiffany M Juarez, Jaya M Gill, Annie Heng, et al.Journal of Neuro-Oncology|June 6, 2018
Rethinking medulloblastoma from a targeted therapeutics perspectiveYuuri Hashimoto, Marta Penas-Prado, Shouhao Zhou, et al.Cancer Cell|March 15, 2011
The central nervous system-restricted transcription factor Olig2 opposes p53 responses to genotoxic damage in neural progenitors and malignant gliomaShwetal Mehta, Emmanuelle Huillard, Santosh Kesari, et al.Oncology Nursing Forum|June 22, 2017
Anxiety and Depression Associated With Burden in Caregivers of Patients With Brain MetastasesMarlon G Saria, Natasia S Courchesne, Lorraine Evangelista, et al.Alzheimer'S & Dementia (New York, N. Y.)|August 24, 2019
Focused transcranial ultrasound for treatment of neurodegenerative dementiaNatalie Eleanor Nicodemus, Sergio Becerra, Taylor P Kuhn, et al.Pageof 36